Phenylalanine

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Phenylalanine, often sold as L-phenylalanine or DL-phenylalanine, is an essential amino acid that is normally converted to tyrosine.[1][2][3]

Theory[edit | edit source]

McGregor (2019) found that in people with ME/CFS, the 7-day severity of post-exertional malaise (PEM) and the 12-month frequency of PEM scores correlated with blood glucose levels, and negatively correlated with hypoxanthine, phenylalanine, lactate and threonine.[4]

Evidence[edit | edit source]

Risks and safety[edit | edit source]

Phenylalanine is generally recognized as safe, except for people with phenylketonuria (PKU), a genetic disorder that prevents the metabolism of phenylalanine.[3] Phenylalanine is found in many different foods.

Costs and availability[edit | edit source]

Inexpensive and available over the counter as a nutritional supplement.

Notable studies[edit | edit source]

  • 2016, Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome[5] (Full Text)
  • 1977, DL-phenylalanine in depressed patients: An open study[6] (Abstract)
  • 2019, Post-exertional malaise is associated with hypermetabolism, hypoacetylation and purine metabolism deregulation in ME/CFS cases[4] - (Full text)

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. "Definition of PHENYLALANINE". Merrian-Webster Dictionary. Retrieved March 7, 2021.
  2. "Phenylalanine". go.drugbank.com. Retrieved March 7, 2021.
  3. 3.0 3.1 PubChem. "DL-Phenylalanine". pubchem.ncbi.nlm.nih.gov. Retrieved March 7, 2021.
  4. 4.0 4.1 McGregor, Neil R.; Armstrong, Christopher W.; Lewis, Donald P.; Gooley, Paul R. (September 2019). "Post-Exertional Malaise Is Associated with Hypermetabolism, Hypoacetylation and Purine Metabolism Deregulation in ME/CFS Cases". Diagnostics. 9 (3): 70. doi:10.3390/diagnostics9030070.
  5. Fluge, Øystein; Mella, Olav; Bruland, Ove; Risa, Kristin; Dyrstad, Sissel E.; Alme, Kine; Rekeland, Ingrid G.; Sapkota, Dipak; Røsland, Gro V.; Fosså, Alexander; Ktoridou-Valen, Irini; Lunde, Sigrid; Sørland, Kari; Lien, Katarina; Herder, Ingrid; Thürmer, Hanne; Gotaas, Merete E.; Baranowska, Katarzyna A.; Bohnen, Louis M.L.J.; Schäfer, Christoph; McCann, Adrian; Sommerfelt, Kristian; Helgeland, Lars; Ueland, Per M.; Dahl, Olav; Tronstad, Karl J. (2016). "Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome". JCI Insight. 1 (21): e89376. doi:10.1172/jci.insight.89376.
  6. Beckmann, H.; Strauss, M.A.; Ludolph, E. (June 1, 1977). "Dl-phenylalanine in depressed patients: An open study". Journal of Neural Transmission. 41 (2): 123–134. doi:10.1007/BF01670277. ISSN 1435-1463.